- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/21 - Retroviridae, p.ex. virus de l'anémie infectieuse équine
Détention brevets de la classe A61K 39/21
Brevets de cette classe: 1625
Historique des publications depuis 10 ans
120
|
87
|
104
|
102
|
88
|
88
|
76
|
66
|
74
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Duke University | 3008 |
80 |
The Trustees of the University of Pennsylvania | 4255 |
51 |
The Scripps Research Institute | 1352 |
46 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2829 |
45 |
International AIDS Vaccine Initiative | 87 |
43 |
Janssen Vaccines & Prevention B.V. | 334 |
31 |
Triad National Security, LLC | 587 |
31 |
The Regents of the University of California | 19493 |
25 |
Beth Israel Deaconess Medical Center, Inc. | 859 |
23 |
Centre National de La Recherche Scientifique | 10068 |
22 |
Massachusetts Institute of Technology | 9909 |
22 |
Oregon Health & Science University | 757 |
18 |
Emory University | 1586 |
17 |
Glaxosmithkline Biologicals S.A. | 1697 |
16 |
American Gene Technologies International Inc. | 88 |
16 |
Baylor Research Institute | 242 |
15 |
Inovio Pharmaceuticals, Inc. | 318 |
15 |
Los Alamos National Security, LLC | 311 |
15 |
California Institute of Technology | 3929 |
14 |
Bionor Immuno AS | 21 |
14 |
Autres propriétaires | 1066 |